ABSTRACT. Primary arteritis of the central nervous system (CNS) comprises a heterogeneous group of CNS disorders, which is characterised by non-atheromatous inflammation and necrosis of the arterial wall. The clinical presentation is highly variable, with stroke being the most common manifestation. Conventional angiography is considered to be the best imaging tool for diagnosing the disease. However, angiographic findings, which usually show lumen irregularities and stenosis, are often unspecific and can occur with a variety of other vascular disorders, such as atherosclerosis and arterial dissection. Therefore, brain biopsies are often needed to confirm the diagnosis. Recent reports have shown that MRI is able to visualise contrast enhancement in subjects with known primary CNS arteritis. This case report suggests that high-resolution contrastenhanced, black-blood T 1 weighted images with fat suppression might be useful for diagnosising intracranial arteritis. This MRI technique has the potential to replace invasive procedures, such as conventional angiography and/or brain biopsies. Furthermore, it provides information about the inflammatory activity of the disease and might be useful for monitoring anti-inflammatory therapy. Further studies are needed to confirm these initial promising results.
This case report suggests that high-resolution contrastenhanced, black-blood T 1 weighted images with fat suppression might be useful for diagnosising intracranial arteritis. This MRI technique has the potential to replace invasive procedures, such as conventional angiography and/or brain biopsies. Furthermore, it provides information about the inflammatory activity of the disease and might be useful for monitoring anti-inflammatory therapy. Further studies are needed to confirm these initial promising results.
We report the case of a 63-year-old woman with right latent hemiparesis, dysarthria, ataxia and a neuropsychological disorder with a depressive syndrome. She had suffered from a stroke affecting the pons and the left thalamus 3 months before admission to our hospital. Furthermore, the patient complained of severe and frequent headaches, and chronic fatigue. A recent oral infection with herpes simplex virus (HSV), which was treated with acyclovir, was also reported. She presented with no cardiovascular risk factors. Blood tests showed no signs of systemic inflammation. Electrocardiogram and echocardiography were normal. Duplex sonography revealed no significant stenosis in the cervical arteries, although blood flow velocity was increased in the basilar artery (85/40 cm s ) and an increased protein content (63 mg dl -1 ). Polymerase chain reaction (PCR) for HSV, varicella zoster virus (VZV), Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were negative. Serological screening for vasculitis (rheumatic factors, complement C3/C4, anti-nuclear antibody (ANA), anti-neutrophil cytoplasmic antibody (ANCA) angiotensin converting enzyme (ACE) was negative.
For further diagnostic workup, the patient was referred to the radiology department for a magnetic resonance (MR) scan. All MR examinations were performed on a clinical high-field MR imager (3.0 Tesla Magnetom Verio, Siemens Healthcare, Erlangen, Germany).
Time-of-flight intracranial MR angiography ( Figure 1a ) showed unspecific lumen irregularities in the basilar and both posterior cerebral arteries (PCA). T 2 weighted turbo spin echoes of the brain (Figure 1b) showed old ischaemic infarcts in the right and left pons and in the left thalamus. Diffusion-weighted images revealed no recent ischaemic infarction or signs of encephalitis, although a slight hyperintensity was noted in both cerebellar peduncles, as an unspecific sign for cerebellitis.
High-resolution, black-blood fat suppressed pre-and post-contrast T 1 weighted images (double inversion recovery turbo spin echo) were performed using a 12-channel head coil (best in-plane interpolated resolution 0.2 6 0.2 mm 2 , slice thickness 2 mm). The delayedenhancement T 1 weighted sequence 5 min after the intravenous injection of 0.1 mmol kg -1 (0.2 ml kg -1 ) gadolinium-DTPA-BMA (Gadobutrol, Bayer Schering, Leverkusen, Germany) showed strong contrast enhancement in the vessel walls of the distal basilar artery, the posterior cerebral arteries and the left posterior communicating artery (Figure 1c) , suggesting intracranial arteritis. No arterial contrast enhancement was seen in the middle and anterior cerebral arteries (Figure 1c ). Owing to the high suspicion of intracranial arteritis on MRI, the clinical symptoms and the cerebrospinal fluid (CSF) results, a systemic therapy with endoxan and steroids was started immediately. Shortly after the initiation of the therapy, an improvement of the sensomotoric symptoms and of the dysphoric/depressive mental state of the patient were noted. A follow-up examination 3 months after the initiation of therapy (images not shown) revealed a slight decrease in contrast enhancement on the MR images. At the same time CSF showed a decrease in the cell count from 51 to 33/3 mm -3 while protein content decreased from 63 mg dl -1 to 50 mg dl -1 . However, the patient still suffered from recurrent headaches and fatigue, and endoxan/steroid combination therapy was continued. 6 months after initiation of anti-inflammatory therapy the headaches and fatigue disappeared. At the same time, MRI showed a substantial decrease in the contrast enhancement of the arterial wall in the basilar artery and right cerebral artery (Figure 1d ) and an absence of contrast enhancement in the left communication artery and left posterior cerebral artery. CSF showed a further decrease in the cell count to 24/3/mm 3 while protein content remained at the same level seen after 3 months. These findings suggest that MRI is able to visualise the inflammatory activity of primary central nervous system (CNS) vasculitis with good correlation to the clinical status of the patient. Primary arteritis of the CNS comprises a heterogeneous group of CNS disorders that is characterised by non-atheromatous inflammation and necrosis of the arterial wall [1] . The clinical presentation is highly variable, with stroke being the most common manifestation [2] .
Conventional angiography is considered to be the best imaging tool to diagnose the disease. However, angiographic findings, which usually show lumen irregularities and stenosis, are often unspecific and can occur with a variety of other vascular disorders, such as atherosclerosis and arterial dissection. Therefore brain biopsies are often needed to confirm the diagnosis [3] .
Black-blood pre-and post-contrast T 1 weighted sequences with fat suppression enable the delineation of the arterial wall from the lumen and the surrounding perivascular tissue. Furthermore, post-contrast T 1 weighted sequences allow visualising contrast enhancement of the arterial wall. To date, these sequences have been used successfully to evaluate the composition and morphology of the carotid atherosclerotic plaque [4] and to assess the mural enhancement in the superficial temporal artery in giant cell arteritis [5] . Recent reports have shown that MRI is able to visualise contrast enhancement in subjects with known primary CNS arteritis [6] .
In our patient strong, mural contrast enhancement was seen in several intracranial arteries, which decreased substantially after 6 months of anti-inflammatory therapy. The extent of the contrast enhancement and the distribution of the enhancement was atypical of atherosclerotic disease, in which contrast enhancement is generally weaker, does not compromise the whole vessel wall and is commonly localised at the shoulder region of the atherosclerotic plaque [4] .
This case report suggests that high-resolution contrastenhanced, black-blood T 1 weighted images with fat suppression might be useful for the diagnosis of intracranial arteritis. This may allow invasive procedures to be replaced, such as conventional angiography and/or brain biopsies. Furthermore, this MRI technique provides information about the inflammatory activity of the disease and might be useful for monitoring antiinflammatory therapy. Further studies are needed to confirm these initial promising results.
